The reason we are at 6 cents is this company is still in the r&D phaze. This keeps REAL investors away, they are waiting for an actual idea of the revenue that can be made and the stock will be kept in the gutter until that information comes to light.
Hey guys ACTC financials suck and they have no revenue OH really no duhh???? I don't know where you think they would earn money at this point. The point is they are by far the closest company to earning revenue from stem cell related procedures.
ACTC has stated plenty of times they will only do the R/S if we can join the nasdaq which requires a 4.00 share price. I think given all the financial forces trying to keep this company down will not be put to rest without us getting to the Nasdaq. The news that comes out now is far more meaningful and in a different league than the information that use to drive us close to .30 cents. Clearly there are too many eyes, too many people gaining 1 percent at a time and this needs to have a defense against this.
News 
Market Data 
Discover 
AI
